Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE flat, DAX flat, CAC (0.1%), IBEX (0.2%), MIB (0.1%)

Jul 06 ,2026

  • Synopsis

    • European equity markets are set to open broadly flat to lower, following last week's gains. STOXX Europe 600 rose +2.66% last week, hitting fresh record highs. Oil prices and bond yields extended the recent decline following the easing of Middle East tensions, which was reinforced by lower-than-expected Eurozone inflation and reduced the urgency for further rate increases.

    • Asian equities mixed Monday. Tech-led retreat in South Korea and Japan with Taiwan erasing early gains. S&P 500 futures slightly higher as US markets resume trade Monday following Independence Day long weekend. Crude fluctuating with Middle East supply on the rise. Gold and silver remain higher. Bitcoin back to two-week high.

    • European macro data releases out today include Germany May factory orders, Jun construction PMI, Switzerland Jun unemployment rate, Eurozone Jul economic index - Sentix, May PPI, retail sales, UK Jun construction PMI, Denmark May industrial production, Ireland Jun unemployment rate

    • In central banks, Bank of Italy hosts conf (through Tue) on challenges for monetary policy transmission in a changing world (ChaMP), ECB's Schnabel chairs panel including Riksbank's Seim at 17:00CET and ECB's Lane speech at 20:30CET, whilst ECB's Lagarde in on-stage conversation at 18:00CET at 15th anniversary event of Financi'Elles. Croatia central bank's Žigman introductory speech/panellist at 10:00CET at annual meeting of Croatian regulators, BOE's Mann panellist at 17:30BST at Royal Economic Society (RES) conf (through Wed) and Latvia central bank's Rutkaste participates at 12:05CET in the Latvian Radio program 'Krustpunktā'. In politics, in the UK, there are MPs questions on defence at 14:30BST followed by National Security (State Threats) Bill continuing its passage through parliament, whilst Chinese foreign minister Wang Yi starts a visit to Norway. In Germany, Federal Employment Agency and the German TUC Baden-Württemberg co-host event on the potential and challenges of AI in companies. Elsewhere, Fitch Rating webinar at 14:00BST title life insurance consolidation: dynamics, risks, and regulatory influence and Politico Pro Briefing at 16:00CET title Uneasy alliance: What to expect at this week's NATO summit. There's the release of UK Jun new car registrations.

    • In M&A, Novartis [NOVN.SW] agreed to acquire Myricx Bio for $1.1B upfront plus $400M in milestones, while Continental [CON.GR] announced the sale of its ContiTech division to Lone Star Funds for €4.0B, planning to return €2.5B to shareholders. EasyJet [EZJ.LN] reached an agreement in principle with Castlelake for a recommended cash offer at £6.90 per share. Thales [HO.FP] will acquire a 35.51% stake in Exail Technologies [EXA.FP] with a view to a full takeover at €134/share (implying a €3.9B enterprise value), while also flagging a ~€450M exceptional charge in H1 2026 related to the termination of the F126 programme. ING [INGA.NA] acquired a ~40% stake in Spanish wealth manager Singular Bank, and Siemens Healthineers [SHL.GR] is reportedly looking to carve out its Diagnostics division within 24 months. Next [NXT.LN] is said to be eyeing a bid for Harvey Nichols. Notable broker changes: HSBC upgraded GSK [GSK.LN], while downgrading Merck [MRK.GR] and Roche [RO.SW]. Antofagasta [ANTO.LN] was upgraded to Overweight at JPMorgan, and Societe Generale [GLE.FP] and Quilter [QLT.LN] were both upgraded to Buy at Kepler Cheuvreux.

  • Politics/Macro/World News

    • Burnham warned over lack of cabinet as Number 10 transition talks step up (FT)

    • ECB's Nagel Stresses Need for Vigilance at Next Rate Decision (Bloomberg )

    • Germany Plans to Boost 2027 Borrowing on Weak Tax Revenues (Bloomberg )

    • OPEC+ approves further oil output increase as Hormuz exports start to recover (Reuters )

  • Top company news

    • Earnings/updates

      • HO.FP (Thales) -- specifies effects of termination of F126 program and increases several of its objectives for 2026; to record exceptional and mostly non-cash charge of about €450M in H1 of 2026

      • WIHL.SS (Wihlborgs Fastigheter) -- reports H1 EPS SEK2.76 vs year-ago SEK2.87

      • Also reporting today

        • Earnings:

          • Nordics: Catena (CATE.SS), Fabege (FABG.SS), Wallenstam (WALL.B.SS)

          • UK: BTG Consulting (BTG.LN), Knights Group Holdings (KGH.LN)

        • Trading Update:

          • DACHs: GEA Group (G1A.GR)

          • Southern Europe: Repsol (REP.SM)

        • Traffic: Norwegian Air Shuttle (NAS.NO), Icelandair Group (ICEAIR.IR)

        • CMD/Events: AstraZeneca (AZN.LN) sustainability highlights call at 14:30BST (link), GEA Group (G1A.GR) pre-close call, Aumovio SE (AMV0.GR) pre-close call

    • M&A

      • NOVN.SW (Novartis) -- agrees to acquire Myricx Bio fro $1.1B upfront, with up to $400M in potential milestone payments

      • INGA.NA (ING) -- acquires ~40% non-controlling stake in Spanish wealth manager Singular Bank; price not disclosed

      • CON.GR (Continental) -- to sell ContiTech to Lone Star Funds for EV of €4.0B, plans to return €2.5B to holders

      • EZJ.LN (EasyJet) -- EasyJet, Castlelake reach agreement in principle on key financial terms of recommended cash offer at £6.90 per share in cash

      • EXA.FP (Exail Technologies) --

        • Thales signs agreement with Gorgé family concert for acquisition of their combined 35.51% stake in Exail Technologies with view to acquiring 100% of Exail; this is through a mandatory tender offer, in each case for a price of €134.00 per share; implies an enterprise value for Exail of €3.9B

        • Exail Technologies, Safran end discussions regarding Safran's possibly buying Exail Technologies

      • UBER (Uber Technologies) -- Uber pulls back on expansion into European food delivery, says FT - Reuters

      • KKR (KKR & Co.) -- Brookfield to bid for KKR's Colonial First State business which is valued at A$5-6B ($3.48-4.16B) -- The Australian

      • SHL.GR (Siemens Healthineers) -- seeking to carve out Diagnostics division within 24 months - Börsen Zeitung

      • NXT.LN (Next) -- to make play for Harvey Nichols - Sky News

      • EQT.SS (EQT AB) -- to acquire Orikan, terms undisclosed

      • DOKA.SW (dormakaba Holding) -- acquires Style Group; terms not disclosed

      • BAMI.IM (Banco BPM) -- Credit Agricole now holds 29.3% of Banco BPM

      • 543A.JP (ARCHION) -- to conduct secondary offering (for holders Toyota Motor, Daimler Truck) of 787.9M shares

    • Healthcare

      • ADOC.FP (Adocia) -- announces expiration of Sanofi's three-year exclusive right to negotiate a partnership agreement for the development of M1Pram

    • Other

      • P911.GR (Porsche) -- could cost up to 4,000 more jobs - Handelsblatt

      • SKA.B.SS (Skanska) -- builds rock caverns for final repository of short-lived radioactive waste in Forsmark for ~SEK 1B

      • DKSH.SW (DKSH Holding) -- signs strategic partnership with Lilly to expand pharmaceutical sales and distribution in Hong Kong and Macau

      • Canadian PM Carney to announce winner of Canadian Submarine project winner tomorrow (6-Jul)- Globe and Mail, citing government sources

      • Estimated weekend box office revenues in US, Canada $119.4M, (23.2%) y/y - Box Office Mojo

  • Key rating changes

    • Upgrades

      • HSBC upgrades GILD, GSK.LN; downgrades MRK.GR, PFE, RO.SW

      • ANTO.LN (Antofagasta) -- to overweight from neutral at JPMorgan

      • CAST.SS (Castellum AB) -- to equal weight from underweight at Barclays

      • XFAB.FP (X-FAB Silicon Foundries) -- to buy from hold at Kepler Cheuvreux

      • GLE.FP (Societe Generale) -- to buy from hold at Kepler Cheuvreux

      • QLT.LN (Quilter) -- to buy from hold at Kepler Cheuvreux

      • UNI.SM (Unicaja Banco) -- to buy from hold at Kepler Cheuvreux

    • Downgrades

      • HSBC downgrades MRK.GR, PFE, RO.SW

      • SESG.FP (SES) -- to underweight from equal weight at Barclays

    • Other Actions

      • NEM.GR (Nemetschek) -- resumed buy at Deutsche Bank; prior rating was buy

      • PPC.GA (Public Power Corp) -- initiated overweight at Morgan Stanley

  • Data

    • Nikkei (0.48%) to 69407.20

    • Hang Seng +0.76% to 23527.98

    • Shanghai Composite +0.16% to 4050.12

    • S&P futures +21.5 vs prior close of 7528.3

    • €-$ (0.0009) or (0.08%) to 1.1428

    • $-¥ +0.72 or +0.44% to 162.04

    • €-¥ +0.66 or +0.36% to 185.16

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.